Objective We aimed to clarify the prevalence of preexisting Metabolic Syndrome (MetS) defined by the Japanese original criteria among patients with non-fatal myocardial infarction (MI). Methods This is a retrospective cohort study using the computer database obtained by the preliminary health checkup from April 2003 to December 2008. We extracted the subjects with newly developed nonfatal MI from the study population. The newly non-fatal MI was diagnosed by the history of coronary heart disease (CHD) and new appearance of abnormal Q wave on electrocardiograms. MetS was diagnosed by using the Japanese original criteria. If waist circumference was not available, BMI was used alternatively. We evaluated the prevalence of preexisting MetS and other risk factors of CHD among the subjects. We compared the prevalence of preexisting risk factors between MetS group and non-MetS group. Results From a study population of 298,455 subjects, 446 subjects with a history of CHD were found. Among the 446, 92 subjects (85 men and 7 women) with abnormal Q wave on electrocardiogram were found. The prevalence of preexisting MetS with non-fatal MI was 19.6% (95% CI; 15.5-23.7%). The prevalence of other preexisting risk factors were 60.0% with smoking history, 55.6% with over-work, 53.3% with stressful life and 36.1% with impaired glucose tolerance. These prevalence rates were not significantly different between MetS group and non-MetS group. Only the prevalence (22.3%) of elevated LDL-cholesterol in the non-MetS group was significantly higher than in the MetS group (14.4%). Conclusion Preexisting MetS may be able to predict only 20% of future MI. To prevent future myocardial infarction, precaution guidance may be required for people with not only preexisting MetS but also other preexisting risk factors of CHD.
Introduction
Coronary heart disease (CHD) is a major cause of death in Japan. Metabolic syndrome (MetS) is one of the important risk factors of CHD (1, 2) . However, the associations between the development of CHD and MetS are controversial (3, 4) . Kasai et al suggested that the associations between the development of coronary arteriosclerosis and MetS were different according to various criteria of MetS (5) .
Medical checkups for MetS diagnosed by the original criteria were started in 2008 for the purpose of promoting lifestyle modifications through health guidance in Japan (6) . So the notion of prevention of MetS has been built up among the Japanese population. However, there are few studies that have clarified the associations between myocardial infarction (MI) and MetS as diagnosed by the Japanese original crite- ria. Ishimaru et al reported that the prevalence of MetS diagnosed by its criteria among patients with acute MI was 51%, and Morioka et al reported that it was 17.5% (7, 8) . These cross-sectional studies investigated the prevalence of MetS among patients with MI at the time when the patients developed MI. To our knowledge, there are no studies that have investigated the prevalence of preexisting MetS defined by its criteria among patients with MI. Estimation of preexisting risk factors including MetS among patients with MI may bring useful information to predict future MI among patients with these risk factors.
The objective of this study clarified the prevalence of preexisting MetS defined by Japanese original criteria and preexisting risk factors among patients with non-fatal MI. And we intended to compare the differences of prevalence and mean value of risk factors of CHD between patients with MetS and those with non-MetS.
Materials and Methods

Study design
This is a retrospective cohort study using the computer database to assess the prevalence of preexisting MetS defined by the Japanese criteria which was presented by the Examination Committee of Criteria for Metabolic Syndrome in April 2005 (9) among patients with non-fatal MI diagnosed by the electrocardiograms in the preliminary health checkups (10) . The original diagnosis of MetS in Japan is defined by the presence of central obesity for which waist circumference of 85 cm for men and 90 cm for women is an essential component, accompanied by the presence of at least two of the following three risk factors: dyslipidemia, elevated blood pressure, and impaired glucose tolerance. This study was approved by the institutional review board and informed consent was obtained from the study population.
Study population and study subjects
The study population had had preliminarily the occupational or regional health checkup at the Seirei Center for Health Promotion and Preventive Medicine in Hamamatsu City, Japan. Hamamatsu City which is located in mid Japan, is a manufacturing area, and with a population of approximately 800 thousand at the end of 2009. The health checkups were conducted from April 2003 to December 2008. All data was registered in the computer database. The health checkups including the electrocardiogram and blood tests were conducted for a study population aged 35, 40 and more. A part of population aged 36 to 39 had had these examinations by recommendation from medical doctors. Study population had had the electrocardiograms in the preliminary health checkups at least two times during the study period, because newly non-fatal MI had been diagnosed by comparing before and after the electrocardiographic findings of the development of newly non-fatal MI. Of the study population, the subjects were patients who developed newly non-fatal MI (Fig. 1) .
Diagnosis of non-fatal MI
To confirm definite non-fatal MI, we extracted all subjects (n=446) who had a past history of MI or CHD from the study population by using the computer database. Subsequently, a cardiovascular specialist reviewed the electrocardiograms of all subjects with its past history of MI or CHD. He detected all subjects who developed the newly MI coinciding with a new appearance of abnormal Q wave on the electrocardiograms. Abnormal Q wave was based on the diagnostic criteria of the Minnesota Code (10). We regarded new abnormal (>0.03 second) Q waves in two or more contiguous leads on electrocardiogram as a development of MI (11) . As a result, 92 subjects with new appearance of abnormal Q wave were considered to have new development of non-fatal MI (Fig. 1) . All measurements were performed using the electrocardiogram analysis software EFS-8000 se-ries (ver2.11; Fukuda Denshi Company, Tokyo).
Data collection and criteria of MetS
The data obtained from the health checkups included demographic characteristics such as age and gender, past history of hypertension, dyslipidemia, diabetes mellitus, MI and CHD, body mass index (BMI), systolic and diastolic blood pressure (BP), fasting blood glucose (FBG), total cholesterol (T-Cho), serum triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), electrocardiogram, and lifestyle, such as smoking habit, the presence or absence of overwork (working over 9 hours per day), presence or absence of stress, presence or absence of symptoms such as palpitation, chest pain and upper abdominal pain within the past month. We reviewed the computer database among the subjects who developed newly non-fatal MI and assessed the preexisting factors such as demographic characteristics, lifestyle, symptoms and laboratory data. These data, obtained at the point of the last health checkups before they developed newly non-fatal MI, were used.
The subjects were defined as having MetS if they had 1) elevated BMI ( 25 kg/m 2 ) and at least two of the following items: 2) elevated systolic BP ( 130 mmHg) and/or diastolic BP ( 85 mmHg) and/or under therapy for hypertension, 3) elevated TG ( 150 mg/dL) and/or lowered HDL-C (<40 mg/dL) and/or under therapy for dyslipidemia, and 4) elevated FBG 110 mg/dL (if fasting blood glucose was not available, postprandial glucose 140 mg/dL or HbA1c 5.5% and/or under therapy for diabetic mellitus, and as having pre-MetS if they had 1) and one of the above items: 2)4 ). As previous studies have commonly used, we used BMI as an alternative of waist circumference because the waist circumference had not been measured in the health checkup before 2007 (12) . Furthermore, we also regarded the following item individually as a risk factor of MI: BMI 25 kg/ m 2 , hypertension (systolic BP 140 and/or diastolic BP 90 mmHg and/or under therapy for hypertension), impaired glucose tolerance (FBG 110 mg/dL or postprandial glucose 140 mg/dL and/or under therapy for diabetes mellitus), dyslipidemia (HDL-C<40 mg/dL and/or TG 150 mg/dL and/or LDL-C 140 mg/dL, and/or under therapy for dyslipidemia), and current or former smoker.
Statistical analysis
First, we calculated the prevalence and 95% confidence intervals (95% CI) of preexisting MetS and other individual risk factors among the subjects with non-fatal MI. Second, we divided the subjects into those with preexisting MetS (MetS group) and those with preexisting non-MetS (nonMetS group). And the prevalence of each preexisting risk factor among MetS group was compared with those with non-MetS group. For these analyses we used the chi-square test or Fisher's exact test for categorical variables and the Student's t-test or Wilcoxon rank sum test for continuous variables appropriately. Finally, the number of preexisting risk factors of the subjects was calculated. We regarded p value of <0.05 as statistically significant. We used the SPSS Ver 12.0 for all analyses.
Results
The total of the electrocardiogram records was 255,007 (men 154,267, women 100,740) in the occupational health checkups, and 43,448 (men 16,063, women 128,125) in the regional health checkups, and the total was 298,455 during April 2003 to December 2008 (Fig. 1) .
We confirmed 92 subjects (85 men and 7 women) who developed the newly non-fatal MI (Fig. 1) . The characteristics of the subjects are shown in Table 1 . Their mean ages ± standard deviation (SD) were 57.0±10.7 years old (men 56± 10.0 years, women 68.4±12.6 years, and ranged from 31 to 96 years). The largest distribution of the subjects was fifties (40 subjects), followed by forties (22 subjects). Their past histories were hypertension (n=48), dyslipidemia (n=32), diabetes mellitus (n=29) including with diabetic retinopathy (n=3), gastric ulcer (n=11), duodenal ulcer (n=10), benign prostatic hyperplasia (n=8), urinary stone (n=7), arrhythmia (n=5), hyperuricemia (n=4), stroke (n=4), and fatty liver (n= 3). The subjects had a family history of CHD including eleven MI (n=17, 18.5%) and stroke (n=13, 14.1%). A woman who developed MI at the age of 42 years old had a past history of ovarian tumor with anticancer drug treatments. Another six women developed MI at older than 65 years old. Only seven subjects had their waist circumference measured, and five of them corresponded with 85 cm which is one of the criteria of MetS. Each mean value ± SD of laboratory data among the subjects with non-fatal MI were FBG (118.4±42.4 mg/dL), HbA1c (6.0±1.4%), TG (165.7±111.8 mg/dL), and LDL-C (144.7±26.2 mg/dL). Hypertension, impaired glucose tolerance, and dyslipidemia were present in 50.5% (n=46), 45.7% (n=42), and 64.4% (n=58) of them.
The antecedent electrocardiographic findings of the development of newly non-fatal MI were normal finding (n=66), sinus bradycardia (n=6), high-voltage of left ventricle (n=4), premature ventricular contraction (PVC) (n=3), left axis deviation (LAD) (n=3), borderline Q wave (n=3), flat bottom T wave (n=2), left ventricular hypertrophy (n=2), sinus tachycardia (n=1), and first-degree atrioventricular block (n= 1). There was no subject who had acute ischemic change on the electrocardiogram. Table 2 shows the prevalence and 95% CI of each preexisting risk factor among the subjects who developed newly non-fatal MI. subjects had answered "I have had a palpitation or chest pain within the last month", and only 4 subjects answered "I have had an upper abdominal pain" before the development of newly non-fatal MI. Of the subjects, 42 (62.7%) were current smokers, 6 (6.5%) were former smokers, and 25 (37.3%) were nonsmokers ( Table 2 ). The mean duration of smoking among current or former smokers was 30.0±8.7 years and the number of cigarettes smoked per day was 21.9±9.1.
Differences in the prevalence of each preexisting risk factor between MetS group and non-MetS group are shown in Table 3 . Mean values of BMI, FBG and HbA1c among MetS group were significantly higher than those among non-MetS group, and the mean value of HDL-C among MetS group was significantly lower than among non-MetS group. Prevalence of BMI of 25 kg/m 2 , hypertension and impaired glucose tolerance among MetS group was significantly higher than those among non-MetS group. On the other hand, the prevalence of dyslipidemia among MetS group was significantly lower than among non-MetS group.
The numbers of preexisting risk factors of CHD per subject with non-fatal MI are shown in Table 4 . There were only two subjects who had no risk factor. Furthermore, 79.2% of them had two or more risk factors.
Discussion
This study clarified that the prevalence of preexisting MetS among subjects with non-fatal MI was 19.6%. In Japan, original health checkups have been started from 2008 to prevent ischemic heart diseases and cerebrovascular diseases with a focus on preexisting MetS (6, 13) . In particular, the prevention of MI, that leads to sudden death, has been one of the primary objectives of the subsequent health guidance following the health checkup. Thus, it was considered that the health check-up for screening preexisting MetS among the population who have not developed MI may be important. However, the results of this study suggested that preexisting MetS can predict only 20% of future MI. Therefore, we considered that it may be necessary to improve not only MetS but also other risk factors in addition to MetS to prevent future MI.
To our knowledge, this is the first study which investigated the prevalence of preexisting risk factors of CHD including MetS among patients with non-fatal MI. Many previous cross-sectional studies have investigated the prevalence (Fig. 2) (14-21) . Investigation of the preexisting risk factors of CHD may be more useful to predict future MI than investigation of the current existing risk factors of CHD. Furthermore, we diagnosed preexisting MetS using the Japanese original criteria. To date, there are few studies using the MetS diagnosed by the Japanese original criteria (Fig. 2) (5, 7, 8) .
We compared the prevalence of MetS with non-fatal MI with those in the previous studies (Fig. 2) . Many previous studies in which the subjects were non-Japanese suggested that the prevalence of MetS among patients with MI ranged from 40 to 60%. The results of previous studies in which the subjects were Japanese showed similar results. Though these studies used various criteria for MetS and the data after the onset of MI, the results were similar. However, our result was relatively low as compared with those in the previous studies. A possible explanation for this result was that there might be some subjects with latent obesity in this study. Hsieh et al indicated that Japanese relatively easily develop lifestyle-related diseases such as diabetes by slight obesity, and even if BMI is lower than 25 kg/m 2 (22) . Another possible explanation is the specificity of this study area. The prevalence reported by Morioka et al was similar to our results (8) . The area where the authors investigated was close to our study area. This study area was an industrial area. So there might be work-related risks such as poor work environment, overwork and heavy work in this study population.
Approximately 80% of the subjects with non-fatal MI had not had the preexisting MetS. The high prevalence of other preexisting risk factors other than MetS among non-MetS group were 60.0% with smoking history, 55.6% with over time work, 53.3% with stressful life and 36.1% with impaired glucose tolerance. However, these prevalences were not significantly higher than those among MetS group (Table 3). Kayaba et al reported that a work-centric lifestyle and social dominance are closely related to the occurrence of CHD in the Japanese population (23) . Smoking is well known as a traditional risk factor of MI (24, 25) . Only the prevalence of dyslipidemia among non-MetS group was significantly higher than that with MetS group (22.3% vs. 14.4%, p<0.05). Dyslipidemia is also well known as an independent risk factor of MI (26, 27) . Even if people are not suitable for the criteria of MetS, it may be necessary to advise them to quit smoking, reduce their stress and lower their LDL-C level. This study showed that 79.2% of the subjects had two or more preexisting risk factors and only two subjects had no risk factor. This proportion was similar to the results of the previous studies which evaluated the number of risk factors of MI among patients without MetS (28) (29) (30) . These findings suggest that a long duration of multiple risks may cause CHD in Japanese. Regardless of the presence or absence of MetS and what types of risk factors people have, people with a risk factor for CHD, and particularly those with two or more risk factors, should be advised to improve their lifestyle.
In Japan, the health check-up and the subsequent health guidance of which its primary objective is to prevent CHD and cerebrovascular diseases by improving lifestyle-related diseases such as MetS has been started (13) . However, the program of which its main target is limited to only people with MetS may not be able to prevent the modest future MI because the prevalence of preexisting MetS among patients with MI was only 20% in this study. To prevent future MI, we propose the health guidance for not only people with MetS but also for those with any factors (dyslipidemia, smoking habit, overwork and stressful life) even if they do not have MetS, especially in the industrial area.
The mean age of the subjects in this study was 57.0±10.7 years old. The mean age of onset of MI in Japan is generally 62-65 years old in men and 70-74 years old in women (31, 33) . In this study, the mean age which the subjects had probably developed MI was relatively younger than the mean age of the general population because the health check-up was based on potentially healthy workers and residents. In this study, males made up 92% of the subjects. Large scale studies have suggested that the male to female ratio of incidence of MI is roughly 7:3 (32, 33) . It is true that in the same way as age, there seems to be a higher prevalence of MI among men.
We used the modified criteria of MetS by employing BMI in place of waist circumference for some of the subjects, because waist circumference was not evaluated for all subjects. We selected BMI of 25 kg/m 2 as the cut-off point of obesity based on the results of a previous study which evaluated the relationship between BMI and waist circumference among Japanese (34). Therefore we considered that BMI may be an alternative for waist circumference. Established MI was defined as the appearance of typical electrocardiographic findings (new abnormal Q waves in at least 2 adjacent leads) in addition to the past history of CHD. The non-fatal MI in this study seemed to be consistent with the criteria of established MI based on the consensus in The Joint European Society of Cardiology and American College of Cardiology Committee for the Redefinition of MI (35) . Thus we considered that the subjects in this study might be representative of a population with non-fatal MI to some extent.
There were several limitations in this study. First, the subjects were patients with non-fatal MI. So we could not evaluate patients with fatal MI. Second, non-fatal MI was diagnosed by the presence of both a past history of ischemic heart disease and newly abnormal Q wave on electrocardiogram. Thus we might not be able to evaluate all non-fatal patients in the study population. Third, the subjects in this study were extracted from the study population who had undergone a health check-up at least one time after they devel-oped the newly MI. Therefore patients who had had no health check-up after they developed the newly MI were not evaluated. Forth, as mentioned above, the area investigated in this study was limited. These limitations might lead to the selection bias for the study subjects. Therefore, the generalizability of this result might be limited. Fifth, though we evaluated preexisting risk factors, the causality might not be referred because this study was a retrospective study. Thus a prospective study is needed to obtain conclusive results. Finally, we used BMI as an alternative for waist circumference. Thus the criteria of MetS in this study might not be completely suitable to the Japanese original criteria.
Conclusion
This study clarified that the prevalence of preexisting MetS among the subjects with non-fatal MI was approximately 20%. Thus preexisting MetS may be able to predict only 20% of future MI. Risk factors such as dyslipidemia, smoking habit, overwork and stressful life should be notable for the targets of the original health check-up and the subsequent health guidance in Japan.
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